キッセイ薬品工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/11/19 | 3,645 | 3,675 | 3,615 | 3,625 | ±0 | ±0% | 37,100 |
| 2024/11/18 | 3,580 | 3,650 | 3,540 | 3,625 | -25 | -0.7% | 62,300 |
| 2024/11/15 | 3,710 | 3,710 | 3,640 | 3,650 | -40 | -1.1% | 32,900 |
| 2024/11/14 | 3,700 | 3,740 | 3,680 | 3,690 | -25 | -0.7% | 38,100 |
| 2024/11/13 | 3,710 | 3,740 | 3,690 | 3,715 | +20 | +0.5% | 54,100 |
| 2024/11/12 | 3,680 | 3,730 | 3,680 | 3,695 | +45 | +1.2% | 53,300 |
| 2024/11/11 | 3,640 | 3,670 | 3,605 | 3,650 | -10 | -0.3% | 77,100 |
| 2024/11/08 | 3,685 | 3,715 | 3,610 | 3,660 | -30 | -0.8% | 78,200 |
| 2024/11/07 | 3,710 | 3,770 | 3,670 | 3,690 | +5 | +0.1% | 121,500 |
| 2024/11/06 | 3,780 | 3,810 | 3,650 | 3,685 | -95 | -2.5% | 141,600 |
| 2024/11/05 | 3,715 | 3,780 | 3,690 | 3,780 | +30 | +0.8% | 66,100 |
| 2024/11/01 | 3,700 | 3,790 | 3,695 | 3,750 | +10 | +0.3% | 48,700 |
| 2024/10/31 | 3,740 | 3,770 | 3,700 | 3,740 | +25 | +0.7% | 78,900 |
| 2024/10/30 | 3,705 | 3,740 | 3,690 | 3,715 | +15 | +0.4% | 105,800 |
| 2024/10/29 | 3,670 | 3,715 | 3,660 | 3,700 | -5 | -0.1% | 43,400 |
| 2024/10/28 | 3,670 | 3,725 | 3,665 | 3,705 | +20 | +0.5% | 46,200 |
| 2024/10/25 | 3,750 | 3,760 | 3,675 | 3,685 | -65 | -1.7% | 47,500 |
| 2024/10/24 | 3,740 | 3,760 | 3,705 | 3,750 | -5 | -0.1% | 62,300 |
| 2024/10/23 | 3,780 | 3,820 | 3,755 | 3,755 | -25 | -0.7% | 52,700 |
| 2024/10/22 | 3,830 | 3,830 | 3,775 | 3,780 | -55 | -1.4% | 54,000 |
| 2024/10/21 | 3,850 | 3,865 | 3,830 | 3,835 | -15 | -0.4% | 59,200 |
| 2024/10/18 | 3,850 | 3,910 | 3,850 | 3,850 | +35 | +0.9% | 71,700 |
| 2024/10/17 | 3,790 | 3,830 | 3,790 | 3,815 | +30 | +0.8% | 56,600 |
| 2024/10/16 | 3,755 | 3,830 | 3,755 | 3,785 | +5 | +0.1% | 54,000 |
| 2024/10/15 | 3,785 | 3,810 | 3,770 | 3,780 | +20 | +0.5% | 57,800 |
| 2024/10/11 | 3,720 | 3,760 | 3,710 | 3,760 | +10 | +0.3% | 75,700 |
| 2024/10/10 | 3,725 | 3,750 | 3,715 | 3,750 | +25 | +0.7% | 69,600 |
| 2024/10/09 | 3,700 | 3,730 | 3,675 | 3,725 | +25 | +0.7% | 71,800 |
| 2024/10/08 | 3,710 | 3,765 | 3,680 | 3,700 | -80 | -2.1% | 65,100 |
| 2024/10/07 | 3,700 | 3,785 | 3,660 | 3,780 | +80 | +2.2% | 107,300 |
| 2024/10/04 | 3,640 | 3,735 | 3,640 | 3,700 | +45 | +1.2% | 81,900 |
| 2024/10/03 | 3,630 | 3,670 | 3,585 | 3,655 | +95 | +2.7% | 123,000 |
| 2024/10/02 | 3,610 | 3,625 | 3,550 | 3,560 | -50 | -1.4% | 60,700 |
| 2024/10/01 | 3,545 | 3,615 | 3,540 | 3,610 | +65 | +1.8% | 52,500 |
| 2024/09/30 | 3,510 | 3,570 | 3,485 | 3,545 | -25 | -0.7% | 76,100 |
| 2024/09/27 | 3,540 | 3,610 | 3,525 | 3,570 | -45 | -1.2% | 97,700 |
| 2024/09/26 | 3,560 | 3,620 | 3,560 | 3,615 | +80 | +2.3% | 102,100 |
| 2024/09/25 | 3,535 | 3,555 | 3,500 | 3,535 | ±0 | ±0% | 52,400 |
| 2024/09/24 | 3,515 | 3,545 | 3,470 | 3,535 | +45 | +1.3% | 54,300 |
| 2024/09/20 | 3,535 | 3,565 | 3,465 | 3,490 | -5 | -0.1% | 105,200 |
| 2024/09/19 | 3,505 | 3,550 | 3,495 | 3,495 | +5 | +0.1% | 52,700 |
| 2024/09/18 | 3,510 | 3,520 | 3,460 | 3,490 | +50 | +1.5% | 77,600 |
| 2024/09/17 | 3,540 | 3,540 | 3,400 | 3,440 | -35 | -1% | 80,900 |
| 2024/09/13 | 3,455 | 3,475 | 3,440 | 3,475 | -5 | -0.1% | 52,800 |
| 2024/09/12 | 3,515 | 3,555 | 3,450 | 3,480 | +35 | +1% | 61,800 |
| 2024/09/11 | 3,540 | 3,565 | 3,420 | 3,445 | -110 | -3.1% | 69,500 |
| 2024/09/10 | 3,545 | 3,575 | 3,510 | 3,555 | +15 | +0.4% | 34,400 |
| 2024/09/09 | 3,510 | 3,580 | 3,450 | 3,540 | +10 | +0.3% | 80,700 |
| 2024/09/06 | 3,580 | 3,580 | 3,520 | 3,530 | -25 | -0.7% | 26,700 |
| 2024/09/05 | 3,550 | 3,580 | 3,535 | 3,555 | +5 | +0.1% | 42,200 |
201～
250
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| キッセイ薬 | 447,000円 | +3.6% | - | 2.68% | 15.06倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 日本新薬 | 329,300円 | +3.6% | -15.3% | 3.77% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 173,400円 | +5.0% | +1.5% | 0.00% | 14.84倍 | 4.18倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サンバイオ | 239,300円 | - | - | 0.00% | - | 110.84倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 389,900円 | -6.4% | -71.8% | 4.87% | 43.42倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
